Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping

NIH RePORTER · NIH · R44 · $103,580 · view on reporter.nih.gov ↗

Abstract

Candidate Eligibility Statement The goal of this diversity supplement application is to provide career development support for Dr. Allison Hickman, a bioinformatician who aspires to (and with support could perform) leadership roles in commercial science. Women have been under-represented in science leadership, particularly in the field of bioinformatics, and this award would formally address the issue by supporting a truly talented individual. Dr. Hickman is a US citizen and full-time employee at EpiCypher Inc., a Small Business Concern (SBC) eligible to submit applications to the National Institutes of Health. EpiCypher was recently awarded an SBIR Fast-Track Grant from NHGRI [R44 HG011875] that is currently in year one (of three) and is eligible for diversity supplement support. 5.12.2022 Dr. Allison Hickman - Diversity Supplement Candidate (Research Scientist) Date 5.11.2022 Dr. Martis Cowles - EpiCypher Signing Official (Chief Business Officer) Date

Key facts

NIH application ID
10622310
Project number
3R44HG011875-01A1S1
Recipient
EPICYPHER, INC.
Principal Investigator
Michael-Christopher Keogh
Activity code
R44
Funding institute
NIH
Fiscal year
2022
Award amount
$103,580
Award type
3
Project period
2022-02-01 → 2023-01-31